JOHN ALDRICH N ALEJANDRO
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family SANTA ANA, CA NPI 1891242293
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family CA Neurocrine BioSciences, Inc. All categories
General Payments — all program years on this page
$3,349.38
- Category: General Payments
- Program years: PY2021–2024
- Record count: 30
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $708.00 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $708.00 | 7 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Neurocrine BioSciences, Inc. | $236.34 | 2 |
| Acerta Pharma LLC | $126.89 | 1 |
| Novo Nordisk AS | $120.39 | 1 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $120.39 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $85.87 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $18.12 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1086348175 | Bayer Healthcare Pharmaceuticals Inc. | $85.87 | 07/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1092720382 | Boston Scientific Corporation | $18.12 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1100601745 | Novo Nordisk Inc | $120.39 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105631041 | AstraZeneca Pharmaceuticals LP | $126.89 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1118840629 | Otsuka Pharmaceutical Development & Commercialization, Inc. | $120.39 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1150920246 | Neurocrine Biosciences, Inc. | $126.45 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1150924740 | Neurocrine Biosciences, Inc. | $109.89 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.